Ipca remains on a robust growth path in domestic formulation segment, as the company not only delivered healthy double-digit ...
The changing competitive landscape will be a key monitorable, says Motilal Oswal.
North America dominated the market in 2025, capturing more than 32.6% share and generating USD 1.66 billion in revenue.